Get started
Author

Tobias Meischl

Observed names: Meischl, Tobias, T Meischl, T. Meischl, T., Meischl
ORCID: 0000-0002-1716-9166
Observed ORCID: 0000-0002-1716-9166
OpenAlex ID: A5019346703
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
2021 · Bernhard Scheiner, Katharina Pomej, et al. · Journal of Hepatology · 318
PDF
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline—A Multinational Registry Analysis
2023 · Daniel D. Fraughen, Auyon J. Ghosh, et al. · American Journal of Respiratory and Critical Care Medicine · 60
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
2021 · Fabian Finkelmeier, Bernhard Scheiner, et al. · Liver Cancer · 43
PDF
C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation
2019 · Tobias Meischl, Susanne Rasoul-Rockenschaub, et al. · PLoS ONE · 31
PDF
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
2023 · Tobias Meischl, Karin Schmid-Scherzer, et al. · Respiratory Research · 22
PDF
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital
2021 · Katharina Pomej, Bernhard Scheiner, et al. · PLoS ONE · 19
PDF
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
2021 · Katharina Pomej, Lorenz Balcar, et al. · Journal of Hepatocellular Carcinoma · 17
PDF
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
2020 · Judith Stift, Georg Semmler, et al. · Digestive and Liver Disease · 17
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
2020 · Katharina Pomej, Bernhard Scheiner, et al. · Cancers · 16
PDF
Anaemia is independently associated with mortality in patients with hepatocellular carcinoma
2024 · T. Meischl, L. Balcar, et al. · ESMO Open · 15
PDF
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
2021 · Nataliya Rohr‐Udilova, Kaoru Tsuchiya, et al. · Hepatology Communications · 15
PDF
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion
2024 · Lorenz Balcar, Arpad Mrekva, et al. · Cancer Imaging · 13
PDF
Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
2020 · Tobias Meischl, Susanne Rasoul‐Rockenschaub, et al. · United European Gastroenterology Journal · 11
PDF
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients
2023 · Lorenz Balcar, David Bauer, et al. · PLoS ONE · 10
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
2024 · Katharina Pomej, Lorenz Balcar, et al. · United European Gastroenterology Journal · 8
Cabozantinib in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort.
2020 · Fabian Finkelmeier, Bernhard Scheiner, et al. · Journal of Clinical Oncology · 5
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma
2026 · Tobias Meischl, Moritz Steurer, et al. · Liver International · 3
Kompetenzen in Psychotherapeutischer Medizin und Psychotherapie erwerben
2023 · Henriette Löffler-Stastka, Margarete Finger-Ossinger, et al. · psychopraxis neuropraxis · 2
PDF
Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score
2021 · B Scheiner, K Pomej, et al. · Zeitschrift für Gastroenterologie · 2
Comparison of the diagnostic quality of aspiration and core biopsy needles for transjugular liver biopsy
2020 · Georg Semmler, Judith Stift, et al. · Journal of Hepatology · 2
Non‐Invasive Stratification of Portal Hypertension in Patients With BCR :: ABL1 ‐Negative Myeloproliferative Neoplasms
2025 · Lorenz Balcar, Lina Degenfeld‐Schonburg, et al. · Liver International · 1
PDF
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry
2021 · Tobias Meischl, Karin Schmid-Scherzer, et al. · European Respiratory Journal · 1
Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib
2021 · K Pomej, L Balcar, et al. · Zeitschrift für Gastroenterologie · 1
Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinoma
2026 · Lorenz Balcar, Leonardo Brunetti, et al. · JHEP Reports
PDF
Late Breaking Abstract - Real-world evidence for severe Alpha-1 Antitrypsin Deficiency: Life-years gained for augmentation therapy versus standard care
2025 · Gerry Mcelvaney, Daniel D. Fraughen, et al. · European Respiratory Journal
Works count: 60
Citation count: 632
H-index: 12
I10-index: 14
Year
Topic
Type